Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data.

Cho, Jeong-Yeon; Kwon, Sun-Hong; Lee, Eui-Kyung; Lee, Jeong-Hoon; Kim, Hye-Lin

Cho, Jeong-Yeon; Kwon, Sun-Hong; Lee, Eui-Kyung; Lee, Jeong-Hoon; Kim, Hye-Lin.

Afiliação

Cho JY; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Kwon SH; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Lee EK; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Lee JH; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Kim HL; College of Pharmacy, Sahmyook University, Seoul, South Korea.

Front Oncol ; 11: 728740, 2021.

Article em En | MEDLINE | ID: mdl-34926248

Palavras-chave

adjuvant therapy; cost-effectiveness; cytokine-induced killer cell; economic evaluation; hepatocellular carcinoma; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google